Orion (271560.KS) Stock Price

Orion Price

KOSDAQ·CLOSED
134,700.00KRW+4,400.00 (+3.32 %)
Market closed

Revenue has compounded at 16.4% per year over the past 7 years to 3.10 T KRW. Earnings per share have grown at 32.1% per year over the last 7 years. Orion's net margin stands at 16.9%, up from 12.0% several years earlier. Orion currently offers a dividend yield of about 0.93%. The payout ratio is around 11% of earnings. The dividend has grown at 11.1% per year over the past 7 years. Analysts set a median price target of 142,800.00 KRW, implying 6.0% above the current price. Of 27 analysts, 23 rate the stock a buy — an overall Buy consensus. The stock trades about 36% above its 52-week low.

Orion stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Orion over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Orion stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Orion's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Orion Stock Price History
DateOrion Price
8/3/2026134,700.00 KRW
7/31/2026130,300.00 KRW
7/30/2026135,300.00 KRW
7/29/2026135,600.00 KRW
7/28/2026129,900.00 KRW
7/27/2026130,300.00 KRW
7/24/2026130,500.00 KRW
7/23/2026129,300.00 KRW
7/22/2026128,600.00 KRW
7/21/2026128,000.00 KRW
7/20/2026126,700.00 KRW
7/16/2026128,400.00 KRW
7/15/2026126,900.00 KRW
7/14/2026132,100.00 KRW
7/13/2026135,300.00 KRW
7/10/2026141,300.00 KRW
7/9/2026134,200.00 KRW
7/8/2026141,100.00 KRW
7/7/2026139,500.00 KRW
7/6/2026136,900.00 KRW
7/3/2026136,600.00 KRW
7/2/2026144,100.00 KRW
7/1/2026136,100.00 KRW
6/30/2026132,300.00 KRW
6/29/2026132,300.00 KRW
6/26/2026125,000.00 KRW
6/25/2026126,800.00 KRW
6/24/2026125,100.00 KRW
6/23/2026125,500.00 KRW
6/22/2026130,100.00 KRW
6/19/2026131,400.00 KRW
6/18/2026132,800.00 KRW
6/17/2026136,300.00 KRW
6/16/2026133,900.00 KRW
6/15/2026134,200.00 KRW
6/12/2026139,000.00 KRW
6/11/2026134,800.00 KRW
6/10/2026132,500.00 KRW
6/9/2026132,900.00 KRW
6/8/2026128,000.00 KRW
6/5/2026132,100.00 KRW
6/4/2026130,700.00 KRW
6/2/2026128,400.00 KRW
6/1/2026127,500.00 KRW
5/29/2026127,700.00 KRW
5/28/2026132,800.00 KRW
5/27/2026133,100.00 KRW
5/26/2026138,300.00 KRW
5/22/2026137,300.00 KRW
5/21/2026135,500.00 KRW
5/20/2026134,700.00 KRW
5/19/2026137,600.00 KRW
5/18/2026136,200.00 KRW
5/15/2026141,500.00 KRW
5/14/2026143,200.00 KRW
5/13/2026137,800.00 KRW
5/12/2026139,100.00 KRW
5/11/2026139,600.00 KRW
5/8/2026141,200.00 KRW
5/7/2026140,000.00 KRW
5/6/2026139,200.00 KRW
5/4/2026142,800.00 KRW
4/30/2026143,600.00 KRW
4/29/2026146,000.00 KRW
4/28/2026141,200.00 KRW
4/27/2026141,400.00 KRW
4/24/2026141,800.00 KRW
4/23/2026145,500.00 KRW
4/22/2026137,100.00 KRW
4/21/2026135,400.00 KRW
4/20/2026135,000.00 KRW
4/17/2026136,900.00 KRW
4/16/2026137,700.00 KRW
4/15/2026138,000.00 KRW
4/14/2026131,400.00 KRW
4/13/2026131,400.00 KRW
4/10/2026132,400.00 KRW
4/9/2026130,400.00 KRW
4/8/2026130,000.00 KRW
4/7/2026130,000.00 KRW
4/6/2026131,200.00 KRW
4/3/2026129,800.00 KRW
4/2/2026130,000.00 KRW
4/1/2026131,800.00 KRW
3/31/2026128,000.00 KRW
3/30/2026127,000.00 KRW
3/27/2026134,500.00 KRW
3/26/2026132,200.00 KRW
3/25/2026134,100.00 KRW
3/24/2026133,400.00 KRW
3/23/2026129,600.00 KRW
3/20/2026137,800.00 KRW
3/19/2026130,600.00 KRW
3/18/2026134,000.00 KRW
3/17/2026131,100.00 KRW
3/16/2026129,000.00 KRW
3/13/2026129,300.00 KRW
3/12/2026130,100.00 KRW
3/11/2026129,000.00 KRW
3/10/2026128,500.00 KRW
3/9/2026126,000.00 KRW
3/6/2026126,500.00 KRW
3/5/2026124,100.00 KRW
2/26/2026135,800.00 KRW
2/25/2026141,000.00 KRW
2/24/2026137,400.00 KRW
2/23/2026136,000.00 KRW
2/20/2026139,500.00 KRW
2/19/2026137,000.00 KRW
2/13/2026139,200.00 KRW
2/12/2026138,600.00 KRW
2/11/2026130,000.00 KRW
2/10/2026128,200.00 KRW
2/9/2026126,500.00 KRW
2/6/2026124,000.00 KRW
2/5/2026123,400.00 KRW
2/4/2026122,000.00 KRW
2/3/2026118,000.00 KRW
2/2/2026117,800.00 KRW
1/30/2026117,500.00 KRW
1/29/2026118,100.00 KRW
1/28/2026117,000.00 KRW
1/27/2026111,000.00 KRW
1/26/2026109,900.00 KRW
1/23/2026116,400.00 KRW
1/22/2026115,600.00 KRW
1/21/2026117,000.00 KRW
1/20/2026115,200.00 KRW
1/19/2026113,100.00 KRW
1/16/2026109,300.00 KRW
1/15/2026108,500.00 KRW
1/14/2026107,300.00 KRW
1/13/2026106,600.00 KRW
1/12/2026106,500.00 KRW
1/9/2026103,100.00 KRW
1/8/2026104,500.00 KRW
1/7/2026104,400.00 KRW
1/6/2026103,800.00 KRW
1/5/2026104,000.00 KRW
1/2/2026103,100.00 KRW
12/30/2025105,700.00 KRW
12/29/2025105,400.00 KRW
12/26/2025106,700.00 KRW
12/24/2025107,700.00 KRW
12/22/2025106,800.00 KRW
12/19/2025106,000.00 KRW
12/18/2025106,100.00 KRW
12/17/2025104,800.00 KRW
12/16/2025105,000.00 KRW
12/15/2025104,700.00 KRW
12/12/2025103,800.00 KRW
12/11/2025101,600.00 KRW
12/10/2025101,500.00 KRW
12/9/2025100,900.00 KRW
12/8/2025104,200.00 KRW
12/5/2025104,100.00 KRW
12/4/2025104,500.00 KRW
12/3/2025104,500.00 KRW
12/2/2025104,000.00 KRW
12/1/2025106,000.00 KRW
11/28/2025105,500.00 KRW
11/27/2025104,900.00 KRW
11/26/2025106,700.00 KRW
11/25/2025102,700.00 KRW
11/24/2025102,300.00 KRW
11/21/2025104,800.00 KRW
11/20/2025105,500.00 KRW
11/19/2025105,200.00 KRW
11/18/2025104,900.00 KRW
11/17/2025105,400.00 KRW
11/14/2025105,400.00 KRW
11/13/2025105,800.00 KRW
11/12/2025106,500.00 KRW
11/11/2025103,100.00 KRW
11/10/2025103,400.00 KRW
11/7/2025103,600.00 KRW
11/5/2025101,800.00 KRW
11/4/2025101,900.00 KRW
11/3/202599,800.00 KRW
10/31/202599,300.00 KRW
10/30/2025100,500.00 KRW
10/29/2025100,800.00 KRW
10/28/2025102,000.00 KRW
10/27/2025102,000.00 KRW
10/24/2025101,200.00 KRW
10/23/2025101,500.00 KRW
10/22/2025102,200.00 KRW
10/21/2025100,400.00 KRW
10/20/2025100,600.00 KRW
10/17/2025100,500.00 KRW
10/16/2025101,500.00 KRW
10/15/2025101,100.00 KRW
10/14/2025100,800.00 KRW
10/13/2025102,100.00 KRW
10/10/2025105,000.00 KRW
10/2/2025103,300.00 KRW
10/1/2025104,900.00 KRW
9/30/2025103,600.00 KRW
9/29/2025105,000.00 KRW
9/26/2025103,700.00 KRW
9/25/2025104,700.00 KRW
9/24/2025104,600.00 KRW
9/23/2025106,100.00 KRW
9/22/2025107,100.00 KRW
9/19/2025108,500.00 KRW
9/18/2025109,600.00 KRW
9/17/2025108,000.00 KRW
9/16/2025108,800.00 KRW
9/15/2025111,200.00 KRW
9/12/2025109,900.00 KRW
9/11/2025110,400.00 KRW
9/10/2025108,300.00 KRW
9/9/2025107,900.00 KRW
9/8/2025106,200.00 KRW
9/5/2025108,400.00 KRW
9/4/2025107,400.00 KRW
9/3/2025108,200.00 KRW
9/2/2025107,700.00 KRW
9/1/2025108,200.00 KRW
8/29/2025107,800.00 KRW
8/28/2025107,200.00 KRW
8/27/2025107,000.00 KRW
8/26/2025107,500.00 KRW
8/25/2025106,100.00 KRW
8/22/2025106,300.00 KRW
8/21/2025106,700.00 KRW
8/20/2025107,000.00 KRW
8/19/2025108,000.00 KRW
8/18/2025108,200.00 KRW
8/14/2025109,500.00 KRW
8/13/2025108,500.00 KRW
8/12/2025108,700.00 KRW
8/11/2025109,500.00 KRW
8/8/2025112,000.00 KRW
8/7/2025111,100.00 KRW
8/6/2025110,800.00 KRW
8/5/2025109,700.00 KRW
Access this data via the Eulerpool API
Get Free API Key

Orion Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
2.87 T KRW
466.65 B KRW
392.35 B KRW
Jan 1, 2023
2.91 T KRW
492.39 B KRW
376.65 B KRW
Jan 1, 2024
3.10 T KRW
543.59 B KRW
524.59 B KRW
Jan 1, 2025 (e)
3.32 T KRW
659.08 B KRW
411.95 B KRW
Jan 1, 2026 (e)
3.76 T KRW
744.74 B KRW
482.03 B KRW
Jan 1, 2027 (e)
4.02 T KRW
797.32 B KRW
532.91 B KRW
Jan 1, 2028 (e)
4.27 T KRW
847.21 B KRW
574.37 B KRW
Jan 1, 2029 (e)
4.24 T KRW
840.73 B KRW
0.00 KRW

Orion Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 4, 2026, 7:28 PM
 
REVENUET KRW
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMET KRW
EBITB KRW
EBIT MARGIN%
NET INCOMEB KRW
NET INCOME GROWTH%
DIV.KRW
DIV. GROWTH%
SHARESM
201720182019202020212022202320242025e2026e2027e2028e2029e
1.071.932.022.232.362.872.913.103.323.764.024.274.24
–79.545.0010.215.6421.981.366.597.0713.007.066.26-0.76
43.2945.5145.1342.7440.1837.9838.7138.5338.5338.5338.5338.5338.53
0.460.880.910.950.951.091.131.201.281.451.551.651.63
107.43282.18327.59376.12372.91466.65492.39543.59659.08744.74797.32847.21840.73
10.0114.6416.1916.8715.8316.2416.9117.5119.8319.8319.8319.8319.83
75.58139.85215.58267.59257.70392.35376.65524.59411.95482.03532.91574.37–
–85.0354.1524.12-3.6952.25-4.0039.28-21.4717.0110.557.78–
600.00600.00600.00750.00750.00950.001,250.001,250.002,500.003,000.003,600.00––
–––25.00–26.6731.58–100.0020.0020.00––
40.0040.0040.0040.0039.5339.5339.5339.5339.5339.5339.5339.5339.53
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Orion generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Orion retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Orion's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Orion has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Orion's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Orion stock margins

The Orion margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Orion. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Orion.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
42.74 %
16.87 %
12.00 %
Jan 1, 2021
40.18 %
15.83 %
10.94 %
Jan 1, 2022
37.98 %
16.24 %
13.66 %
Jan 1, 2023
38.71 %
16.91 %
12.93 %
Jan 1, 2024
38.53 %
17.51 %
16.90 %
Jan 1, 2025 (e)
38.53 %
19.83 %
12.39 %
Jan 1, 2026 (e)
38.53 %
19.83 %
12.83 %
Jan 1, 2027 (e)
38.53 %
19.83 %
13.25 %

Orion Stock Revenue, EBIT, Earnings per Share

The Orion earnings per share therefore indicates how much revenue Orion has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
55,745.50 KRW
9,403.05 KRW
6,689.65 KRW
Jan 1, 2021
59,589.46 KRW
9,433.88 KRW
6,519.41 KRW
Jan 1, 2022
72,687.42 KRW
11,805.43 KRW
9,925.71 KRW
Jan 1, 2023
73,676.86 KRW
12,456.52 KRW
9,528.41 KRW
Jan 1, 2024
78,533.59 KRW
13,751.69 KRW
13,271.15 KRW
Jan 1, 2025 (e)
84,087.10 KRW
16,673.29 KRW
10,421.43 KRW
Jan 1, 2026 (e)
95,016.49 KRW
18,840.43 KRW
12,194.44 KRW
Jan 1, 2027 (e)
101,724.98 KRW
20,170.63 KRW
13,481.44 KRW

Orion business model & stock analysis

Orion Corp is a Finnish company that operates in the pharmaceutical industry. The company was founded in 1917 and is headquartered in Espoo, Finland. Orion Corp specializes in the development, manufacturing, and marketing of medications, as well as the diagnosis and treatment of diseases. As one of the leading pharmaceutical companies in Finland, Orion Corp is dedicated to researching and developing medications and medical devices to help doctors and their patients worldwide improve their quality of life. Orion Corp's business model focuses on selling prescription and over-the-counter medications, as well as manufacturing generic medications. Additionally, the company is involved in the diagnosis and treatment of diseases such as Parkinson's, cancer, and asthma. The company's main business is centered around three main divisions: pharmaceuticals, diagnostics, and animal health. Within these divisions, Orion Corp has various business areas. In the pharmaceutical division, the focus is on developing medications to combat Parkinson's, cancer, and asthma. The company has a strong product range of Parkinson's treatments that can alleviate symptoms and slow the progression of the disease. Furthermore, the company is involved in the development of cancer medications that can inhibit the growth of cancer cells. Orion Corp is also a key player in asthma treatment. The company produces medications that expand the airways and make breathing easier. In the diagnostics division, Orion Corp's main business is the development and manufacturing of diagnostic devices for diseases such as lung cancer and asthma, as well as products for monitoring blood sugar and cholesterol. Animal health is another important business area for Orion Corp. The company manufactures medications and accessories for animal health and offers a variety of products to veterinarians and breeders. These include, for example, animal vaccines or hormone preparations to increase fertility in animals. Orion's production facilities are located in six countries, including Finland, Germany, France, Russia, the USA, and India. Production within the company primarily takes place in Finland. In addition to manufacturing medications and medical devices, Orion Corp is also a leading producer and developer of raw materials and intermediates for pharmaceutical applications worldwide. In summary, Orion Corp offers a wide range of products and services in the health and animal health fields using the latest scientific knowledge and technologies. The company remains committed to continuously expanding its product and service portfolio and providing patients worldwide with high-quality and effective medications that positively impact their lives.

Orion SWOT Analysis

Strengths

Orion Corp possesses several strengths that set the company apart in the market. One key strength is its strong brand reputation, built over several years of delivering high-quality products and services. This brand recognition gives the company a competitive edge and allows it to attract and retain loyal customers. Additionally, Orion Corp has a robust portfolio of innovative products, which enables it to stay ahead of competitors and meet evolving customer needs. The company also benefits from a highly skilled and knowledgeable workforce, who contribute to its success through their expertise and dedication.

Weaknesses

Although Orion Corp has many strengths, it also faces certain weaknesses that should be addressed. One significant weakness is its reliance on a limited number of key customers or markets. This dependency exposes the company to potential risks if there are changes in the demands or preferences of these customers. Additionally, the company may face challenges in terms of geographical expansion, as it may lack the necessary infrastructure or resources to quickly enter new markets. Furthermore, Orion Corp may have certain internal inefficiencies or decision-making processes that could hinder its operational performance.

Opportunities

Orion Corp operates in an industry with various opportunities for growth and expansion. The increasing global demand for its products presents an opportunity for the company to enter new markets and expand its customer base. Furthermore, advancements in technology provide the potential to develop and introduce innovative products, which can give Orion Corp a competitive advantage. Additionally, partnerships or collaborations with other companies in related industries can open doors to new business opportunities and synergies. Taking advantage of these opportunities can contribute to the company's long-term success.

Threats

Despite its strengths and opportunities, Orion Corp must also be aware of potential threats in the market. One major threat is the intense competition from both established players and new entrants in the industry. This competition can lead to price wars, reduced market share, and decreased profitability. Another significant threat is the ever-changing regulatory landscape, which may introduce new regulations or restrictions that could impact the company's operations. Furthermore, economic fluctuations or global events can create uncertainties and disrupt the demand for Orion Corp's products. Mitigating these threats through strategic planning and adaptability is crucial for maintaining a strong market position.

Orion Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Orion historical P/E ratio, EBIT multiple, and P/S ratio

Orion annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Orion shares outstanding

The number of shares of Orion was 39.53 M in 2025. This indicates how many shares Orion is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
40.00 M Stocks
Jan 1, 2021
39.53 M Stocks
Jan 1, 2022
39.53 M Stocks
Jan 1, 2023
39.53 M Stocks
Jan 1, 2024
39.53 M Stocks
Jan 1, 2025 (e)
39.53 M Stocks
Jan 1, 2026 (e)
39.53 M Stocks
Jan 1, 2027 (e)
39.53 M Stocks

Orion Dividend History

10 years of dividend payments

YearAnnual DividendYoY ChangePayments
20263,500.00KRWYTD—1×
Mar 30, 20263,500.00KRW↑ 40.0%1/1
20252,500.00KRW↑ 100.0%1×
Feb 27, 20252,500.00KRW↑ 100.0%1/1
20241,250.00KRW 0.0%—
20231,250.00KRW↑ 31.6%1×
2022950.00KRW↑ 26.7%1×
2021750.00KRW 0.0%1×
2020750.00KRW↑ 25.0%1×
2019600.00KRW 0.0%1×
2018600.00KRW 0.0%1×
2017600.00KRW—1×

Orion dividend history and estimates

In 2025, Orion paid a dividend amounting to 2,500.00 KRW. Dividend means that Orion distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2020
750.00 KRW
0.00 KRW
Jan 1, 2021
750.00 KRW
0.00 KRW
Jan 1, 2022
950.00 KRW
0.00 KRW
Jan 1, 2023
1,250.00 KRW
0.00 KRW
Jan 1, 2024
1,250.00 KRW
0.00 KRW
Jan 1, 2025
2,500.00 KRW
0.00 KRW
Jan 1, 2026 (e)
0.00 KRW
3,000.00 KRW
Jan 1, 2027 (e)
0.00 KRW
3,600.00 KRW

Orion dividend payout ratio

In 2025, Orion had a payout ratio of 23.99%. The payout ratio indicates the percentage of the company's profits that Orion distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2020
11.21 %
Jan 1, 2021
11.50 %
Jan 1, 2022
9.57 %
Jan 1, 2023
13.12 %
Jan 1, 2024
11.40 %
Jan 1, 2025 (e)
23.99 %
Jan 1, 2026 (e)
24.60 %
Jan 1, 2027 (e)
26.70 %

Current Orion forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
85.19 % (23)
Hold
14.81 % (4)
Sell
0.00 % (0)
12M Price Target
142,800.00
Last Price
134,700.00
Currency
KRW
12M Return Potential
6.01 %
LTM Return
0 %

Orion Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
5/13/20242,341.50KRW-783.66 BKRW-2024 Q1
2/6/20243,005.05KRW-825.93 BKRW-2023 Q4

EESG©

Eulerpool ESG Scorecard© for the Orion stock

52/100
69
Environment
42
Social
46
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions254,383
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees27.9
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Orion shareholder structure

% Name
37.37816%
ORION Holdings Corp
ORION Holdings Corp
4.08197%
Lee (Hwa Gyeong)
Lee (Hwa Gyeong)
3.16750%
MFS Investment Management
MFS Investment Management
1.75672%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
1.74895%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
1.39063%
Pzena Investment Management, LLC
Pzena Investment Management, LLC
...

Orion Beneficial Ownership Filings (SEC 13D/G)

Free Float
56.1%
Float Shares
-
Shares Outstanding
-

Orion Executives and Management Board

24 members · avg. age 57 · 8 % women

SL

Mr. Seung Jun Lee (65)

President, Chief Executive Officer, Director

1.46 B KRW

Management

HP

Mr. Hyeon Sik Park (57)

Managing Director

568.00 M KRW
SP

Mr. Seong Gyu Park (61)

Vice President · since 2022

–
SD

Mr. Seo Won Dahm (35)

Managing Director

–
HG

Mr. Hyeok Yong Gwon (55)

Managing Director

–
SH

Mr. Sang Yil Ha (56)

Managing Director · since 2020

–
HK

Mr. Hyeong Seok Kim (61)

Managing Director

–

Board of Directors

CD

Mr. Cheol Gon Dahm (69)

Chairman

3.08 B KRW
YH

Mr. Yin Cheol Huh (65)

Vice Chairman · since 2014

2.40 B KRW
HL

Ms. Hwa Gyeong Lee (69)

Vice Chairman

2.40 B KRW
WL

Mr. Wuk Lee (66)

Non-Executive Independent Director

–
SN

Mr. Seung Gwon Noh (59)

Non-Executive Independent Director

–
CS

Mr. Chan Yeop Song (64)

Non-Executive Independent Director

–

Orion Supply Chain

Orion Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
8 companies
#Nameβ 1YTrend
1
Kyungnam Pharm
Supplier·Customer·Pharmaceuticals·KR
-0.33
-0.37
-0.13
0.58
0.86
0.82
—
2
Lawson
Customer·Food & Staples Retailing·JP
-0.45
0.71
0.24
0.80
0.53
0.39
—
#Nameβ 1YTrend
1
SAMBO CORRUGATED BOARD
Supplier·Containers & Packaging·KR
0.30
0.77
0.17
0.85
-0.42
—
-0.32
2
Nuvo Pharmaceuticals
Supplier·Customer·Pharmaceuticals·CA
0.25
-0.10
-0.20
0.42
-0.10
—
—
3
Thanh Thanh Cong
Supplier·Thrifts & Mortgage Finance·VN
0.46
-0.53
-0.35
-0.85
-0.86
-0.80
—
4
Olam Group
Supplier·Food & Staples Retailing·SG
-0.14
-0.80
-0.16
-0.20
-0.53
-0.65
—
5
AAK
Supplier·Food Products·SE
-0.01
-0.55
0.52
0.71
0.79
-0.20
0.54

Frequently asked questions about Orion

Orion Corp is primarily present in Finland and several other key international markets. The company has a strong presence not only in its home country but also in various regions across the globe. With a global footprint, Orion Corp operates in several countries and regions, including Europe, North America, Latin America, and Asia. The company's extensive geographical reach allows it to serve a diverse customer base and expand its business worldwide.

The business model of Orion Corp focuses on the development, production, and marketing of pharmaceuticals and active pharmaceutical ingredients (APIs). Orion Corp is a renowned company known for its expertise in the field of neurological medicines, especially Parkinson's disease and Alzheimer's disease. With a strong emphasis on research and development, Orion Corp offers a wide range of prescription drugs, including branded and generic medications to serve patients globally. By combining scientific innovation with a commitment to improving patient well-being, Orion Corp continues to shape the future of healthcare with its pharmaceutical solutions.

Orion Corp is primarily active in the pharmaceutical and healthcare industries.

Orion Corp, a renowned company in the stock market, faces tough competition from several key players in its industry. Some of Orion Corp's main competitors include ABC Inc., XYZ Corporation, and DEF Ltd. These competitors are also highly regarded within the market and offer similar products or services as Orion Corp. However, Orion Corp has managed to maintain its strong market position by consistently delivering innovative solutions, exceptional customer service, and an unwavering commitment to quality. Despite the competition, Orion Corp continues to thrive and stand out among its rivals through its unique offerings and strategic business approach.

Orion Corp is a renowned company in the healthcare industry. Founded in 1917, Orion Corp has a rich history of providing innovative pharmaceutical and diagnostic products. Over the years, the company has expanded its portfolio and established itself as a global leader in various therapeutic areas, including neurology, oncology, and respiratory diseases. With a strong focus on research and development, Orion Corp continually strives to develop groundbreaking treatments that improve patients' lives. Leveraging its expertise and global presence, the company aims to address unmet medical needs and contribute to advancing healthcare worldwide.

Orion Corp has accomplished several significant milestones throughout its history. From its establishment in 1917, the company has continuously expanded its portfolio in pharmaceuticals and diagnostics. With a strong focus on research and development, Orion Corp has successfully introduced innovative treatments and medications to the market. Some notable achievements include the launch of Stalevo, a Parkinson's disease medication, and Simdax, a treatment for acute decompensated heart failure. Moreover, the company has received numerous awards and recognitions for its contributions to the healthcare industry. Orion Corp's dedication to delivering high-quality healthcare solutions has established its position as a renowned and trusted pharmaceutical company in the market.

Orion Corp is a leading company that upholds strong values and a transparent corporate philosophy. With a focus on innovation, quality, and sustainability, Orion Corp aims to provide unparalleled products and services to its customers. The company prioritizes ethical practices, integrity, and social responsibility, striving to make a positive impact on the community and the environment. By incorporating cutting-edge technologies and forward-thinking strategies, Orion Corp remains committed to achieving excellence in its business operations. Through continuous growth and a customer-centric approach, Orion Corp continues to be a trusted and reliable choice in the market.

Analysts currently set an average price target of 142,200.00 KRW for the Orion stock (median: 142,800.00 KRW), implying +5.6 % versus the latest price. The consensus is based on 27 analyst ratings.

Orion Analyst Price Targets 2026

27 analysts currently rate the Orion stock: 23 recommend buying, 4 holding and 0 selling. For 2026, analysts expect Orion to generate revenue of 3.76 T KRW and earnings per share of 12,194.44 KRW.

Orion Analyst Price Targets 2026

Converted at the current exchange rate, the Orion share trades at 81.75 EUR (134,700.00 KRW).

Orion Corporation is a Finnish pharmaceutical company specialized in the development, manufacturing, and marketing of medicinal drugs. The company operates in multiple industries, including the pharmaceutical industry, machinery, and diagnostics. Its main business areas are human pharmaceuticals, animal health, and diagnostics. Orion offers a wide range of drugs for the treatment and prevention of various diseases, specializing in neurological, cardiovascular, urological, cancer, and infectious diseases. The company also produces and distributes pharmaceutical products for animals, as well as diagnostic products for disease detection. In addition, Orion is involved in the production of pharmaceutical machinery such as tablet presses and mixers. The company has a research and development department focused on developing new drugs and technologies, investing continuously in research to improve product quality and acquire valuable patents. Some of Orion's key products include therapies for Parkinson's disease, such as Stalevo and Comtess, and the prostate cancer medication, Xtandi. Orion distributes its products globally and has branches in Europe, Asia, and North America. In summary, Orion's business model revolves around the development, manufacturing, and marketing of a wide range of pharmaceutical products. It operates in multiple industries and has a research and development department dedicated to innovation.

The expected revenue of Orion is 3.76 T KRW. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Orion is 482.03 B KRW. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Orion is currently 11.05. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Orion stock.

The price-to-sales ratio (P/S) of Orion is currently 1.42. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Orion stock.

The Eulerpool Quality Score for Orion is 5/10.

The ISIN of Orion is KR7271560005. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Orion is 271560.KS. The ticker symbol is used to trade Orion shares on the stock exchange.

Over the past 12 months, Orion paid a dividend of 1,250.00 KRW . This corresponds to a dividend yield of about 0.93 %. For the coming 12 months, Orion is expected to pay a dividend of 3,600.00 KRW.

The current dividend yield of Orion is 0.93 %.

Orion pays a dividend, distributed in the months of , , , .

Orion paid dividends every year for the past 1 years.

For the upcoming 12 months, dividends amounting to 3,600.00 KRW are expected. This corresponds to a dividend yield of 2.67 %.

Orion is assigned to the 'Non-cyclical consumption' sector.

To receive the latest dividend of Orion from amounting to 3,500 KRW, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Orion distributed 1,250 KRW as dividends.

The dividends of Orion are distributed in KRW.

All fundamentals and in-depth analysis of Orion

Our stock analysis for Orion stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Orion. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Orion Stock
Orion Revenue→
Orion Stock
Orion Net Income→
Orion Stock
Orion P/E→
Orion Stock
Orion P/S→
Orion Stock
Orion EBIT→
Orion Stock
Orion Dividend→
Orion Stock
Orion Directors Dealings→
Orion Stock
Orion Stocks→
Orion Stock
Orion Market capitalization→
Orion Stock
Orion Debt→
Orion Stock
Orion Liabilities→
Orion Stock
Orion Equity→
Orion Stock
Orion AAQS→
Orion Stock
Orion Employees→
Orion Stock
Orion ROE→
Orion Stock
Orion ROA→
Orion Stock
Orion ROCE→
Orion Stock
Orion News→
Orion Stock
Orion Analyst Price Targets→

Non-cyclical consumption Stocks

ORION HoldingsOrigin EnterprisesOriorOrigin AgritechOrkla AOriental Rise HoldingsOrkla IndiaOrient BeveragesOrsero SpAOrganto FoodsOsia Hyper RetailOrganizacion Soriana SAB de CVAll Stocks A–Z →